Exsulin

Exsulin Corporation is a therapeutic development company that develops and commercializes drugs for the treatment of Type 1 and Type 2 diabetes. Its products include Exsulin, which uses a synthetic version of a natural peptide to induce the regeneration of normally functioning islet cells. The company was founded in 2006 and is headquartered in Burnsville, Minnesota.